CoChat

Collaborative large language models for automated data extraction in living systematic reviews

Open access
Khan, Muhammad Ali, Ayub, Umair, Naqvi, Syed Arsalan Ahmed, Khakwani, Kaneez Zahra Rubab, Sipra, Zaryab bin Riaz, Raina, Ammad, Zhou, Sihan, He, Huan, Saeidi, Amir, Hasan, Bashar, Rumble, Robert Bryan, Bitterman, Danielle S, Warner, Jeremy L, Zou, Jia, Tevaarwerk, Amye J, Leventakos, Konstantinos, Kehl, Kenneth L, Palmer, Jeanne M, Murad, Mohammad Hassan, Baral, Chitta, Riaz, Irbaz bin · 2025 · Journal of the American Medical Informatics Association

Published version of a preprint

Cited by 50

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Objective: Data extraction from the published literature is the most laborious step in conducting living systematic reviews (LSRs). We aim to build a generalizable, automated data extraction workflow leveraging large language models (LLMs) that mimics the real-world 2-reviewer process. Materials and Methods: A dataset of 10 trials (22 publications) from a published LSR was used, focusing on 23 variables related to trial, population, and outcomes data. The dataset was split into prompt development (n = 5) and held-out test sets (n = 17). GPT-4-turbo and Claude-3-Opus were used for data extraction. Responses from the 2 LLMs were considered concordant if they were the same for a given variable. The discordant responses from each LLM were provided to the other LLM for cross-critique. Accuracy, ie, the total number of correct responses divided by the total number of responses, was computed to assess performance. Results: In the prompt development set, 110 (96%) responses were concordant, achieving an accuracy of 0.99 against the gold standard. In the test set, 342 (87%) responses were concordant. The accuracy of the concordant responses was 0.94. The accuracy of the discordant responses was 0.41 for GPT-4-turbo and 0.50 for Claude-3-Opus. Of the 49 discordant responses, 25 (51%) became concordant after cross-critique, increasing accuracy to 0.76. Discussion: Concordant responses by the LLMs are likely to be accurate. In instances of discordant responses, cross-critique can further increase the accuracy. Conclusion: Large language models, when simulated in a collaborative, 2-reviewer workflow, can extract data with reasonable performance, enabling truly “living” systematic reviews.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jamia/ocae325

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 18

  1. Jaiyesimi, 2024, Therapy for stage IV non-small cell lung cancer without driver alterations: ASCO living guideline, version 2023.3, J Clin Oncol, 42, e23, 10.1200/JCO.23.02746 · DOI
  2. Michelen, 2021, Characterising long COVID: a living systematic review, BMJ Glob Health, 6, e005427, 10.1136/bmjgh-2021-005427 · DOI · Paper page
  3. Sutton, 2012, An introduction to conditional random fields, FNT Mach Learn, 4, 267, 10.1561/2200000013 · DOI · Paper page
  4. Hasan, 10.1136/bmjebm-2023-112597 · DOI · Paper page
  5. Kartchner, 2023, 10.18653/v1/2023.bionlp-1.37 · DOI
  6. Ma, 2023, Understanding and mitigating overfitting in prompt tuning for vision-language models, IEEE Trans Circuits Syst Video Technol, 33, 4616, 10.1109/TCSVT.2023.3245584 · DOI
  7. Riaz, 2018, A meta-analysis of randomized controlled trials for efficacy and safety of vascular endothelial growth factor tyrosine kinase inhibitors (VEGF-TKIs) adjuvant therapy in high-risk renal cell cancer (RCC), J Clin Oncol, 36, 4567, 10.1200/JCO.2018.36.15_suppl.4567 · DOI
  8. Siddiqi, 2020, Adjuvant therapy in high-risk renal cell cancer: a systematic review and cumulative meta-analysis, J Clin Oncol, 38, 708, 10.1200/JCO.2020.38.6_suppl.708 · DOI
  9. Naqvi, 2023, The role of volume of disease for treatment selection in patients with metastatic castration sensitive prostate cancer (mCSPC): a living meta-analysis, J Clin Oncol, 41, 5088, 10.1200/JCO.2023.41.16_suppl.5088 · DOI
  10. Naqvi, 2023, Deep prostate-specific antigen response and overall survival in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis, J Clin Oncol, 41, 195, 10.1200/JCO.2023.41.6_suppl.195 · DOI
  11. Riaz, 2023, A living interactive systematic review and network meta-analysis evaluating systemic therapies in metastatic castration-sensitive prostate cancer (mCSPC), J Clin Oncol, 41, 193, 10.1200/JCO.2023.41.6_suppl.193 · DOI
  12. Naqvi, 2022, Indirect comparisons of triplet therapy as compared to novel hormonal therapy doublets in patients with metastatic castration sensitive prostate cancer, J Clin Oncol, 40, 5083, 10.1200/JCO.2022.40.16_suppl.5083 · DOI
  13. Riaz, 2022, First-line treatment options in metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis, J Clin Oncol, 40, 132, 10.1200/JCO.2022.40.6_suppl.132 · DOI
  14. Naqvi, 2022, Triplet therapy in metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis, J Clin Oncol, 40, 136, 10.1200/JCO.2022.40.6_suppl.136 · DOI
  15. Khan, 2024, First-line PARP inhibitors (PARPi) with androgen receptor pathway inhibitors (ARPi) in metastatic castration-resistant prostate cancer (mCRPC): a systematic review and meta-analysis, J Clin Oncol, 42, 173, 10.1200/JCO.2024.42.4_suppl.173 · DOI
  16. Bibi, 2024, Efficacy of first line (1L) poly ADP-ribose polymerase inhibitors (PARPi) in combination with androgen pathway inhibitors (API) by homologous recombination repair (HRR) genes in metastatic castration-resistant prostate cancer (mCRPC): a living meta-analysis, J Clin Oncol, 42, e17059, 10.1200/JCO.2024.42.16_suppl.e17059 · DOI
  17. Khan, 2023, Toxicity profile of Janus kinase inhibitors (JAKi) in patients with myelofibrosis: a report from a living systematic review and meta-analysis, Blood, 142, 6433, 10.1182/blood-2023-188107 · DOI
  18. Valmeekam, 2023, On the planning abilities of large language models—a critical investigation, Adv Neural Inf Process Syst, 36, 75993

Cited by

See all 50

Metadata

Authors
Khan, M. A., Ayub, U., Naqvi, S. A. A., Khakwani, K. Z. R., Sipra, Z. B. R., Raina, A., Zhou, S., He, H., Saeidi, A., Hasan, B., Rumble, R. B., Bitterman, D. S., Warner, J. L., Zou, J., Tevaarwerk, A. J., Leventakos, K., Kehl, K. L., Palmer, J. M., Murad, M. H., Baral, C., & Riaz, I. B.
Venue
Journal of the American Medical Informatics Association
Published
2025-01-21
Volume
32
Issue
4
Pages
638-647
ISSN
  • 1067-5027 (ISSN-L)
  • 1527-974X
OpenAlex
W4406663495
Cited by
50
References
16
FWCI
13.24
Type
journal article
Language
en
Open access
green
Funders
  • National Institutes of Health (U24 CA265879)
  • AstraZeneca

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Collaborative large language models for automated data extraction in living systematic reviews. https://app.cochat.ai/papers/10.1093/jamia/ocae325
The paper
Khan, M. A., Ayub, U., Naqvi, S. A. A., Khakwani, K. Z. R., Sipra, Z. B. R., Raina, A., Zhou, S., He, H., Saeidi, A., Hasan, B., Rumble, R. B., Bitterman, D. S., Warner, J. L., Zou, J., Tevaarwerk, A. J., Leventakos, K., Kehl, K. L., Palmer, J. M., Murad, M. H., . . . Riaz, I. B. (2025). Collaborative large language models for automated data extraction in living systematic reviews. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocae325

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.